Myopia and Presbyopia Treatment Market- Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032
Description
Market Overview
The Myopia and Presbyopia Treatment Market is expected to grow from USD 17,950 million in 2024 to approximately USD 33,969.73 million by 2032, reflecting a compound annual growth rate (CAGR) of 8.3% during the forecast period.
This expansion is primarily driven by the growing global prevalence of both myopia and presbyopia. Lifestyle changes—such as increased screen exposure and decreased outdoor activity—have contributed to a rise in myopia, especially among younger demographics. Concurrently, the global aging population has led to a higher incidence of presbyopia. Technological advancements in treatment options—including cutting-edge contact lenses, refractive surgeries, and emerging drug therapies—are significantly improving clinical outcomes and boosting demand. Rising disposable income levels and heightened public awareness regarding early vision care are also encouraging individuals to seek timely interventions. Furthermore, government-backed initiatives aimed at minimizing visual impairments are helping to support broader market growth.
Market Drivers
Technological Progress in Ophthalmic Treatments
Ongoing innovation in ophthalmology is enhancing the efficiency, accuracy, and accessibility of myopia and presbyopia treatments. New-generation contact lenses with multifocal features and advanced refractive surgeries such as LASIK and SMILE are gaining substantial traction. In parallel, pharmaceutical developments—such as low-dose atropine eye drops for managing myopia and investigational treatments targeting presbyopia’s root causes—are revolutionizing the therapeutic landscape. Notably, FDA-approved corneal inlays like KAMRA and Raindrop offer effective solutions for improving vision at multiple distances. These advances not only broaden treatment choices but also improve clinical success rates, contributing to increased market adoption and patient satisfaction.
Market Challenges
Cost Barriers Limiting Treatment Access
A major challenge hindering market growth is the high cost associated with advanced treatment options. Premium solutions, such as LASIK and SMILE procedures, customized contact lenses, and novel drug therapies, often come with significant out-of-pocket expenses. These treatments are not always covered by insurance, making them less accessible in low- and middle-income regions. Cost-related concerns remain a significant obstacle to widespread adoption, particularly among price-sensitive consumers, thus limiting the reach of advanced care solutions across diverse markets.
Market Segmentation
By Myopia Treatment Type:
Corrective Prescription Lenses:
Single
Bifocal
Trifocal
Others
Contact Lenses
Surgical
Drugs
By Presbyopia Treatment Type:
Prescription Lenses:
Reading Glasses
Bifocals
Trifocals
Progressive Multifocal
Office Progressives
Contact Lenses:
Bifocal
Multifocal
Monovision
Modified Monovision
Intraocular Lenses
Refractive Surgery
By Region:
North America: U.S., Canada, Mexico
Europe: Germany, France, U.K., Italy, Spain, Rest of Europe
Asia Pacific: China, Japan, India, South Korea, Southeast Asia, Rest of Asia Pacific
Latin America: Brazil, Argentina, Rest of Latin America
Middle East & Africa: GCC Countries, South Africa, Rest of the Middle East and Africa
Key Market Participants
ALCON VISION LLC
Bausch & Lomb Incorporated
Essilor Ltd.
Haag-Streit UK
Johnson & Johnson Vision
NIDEK CO., LTD.
Topcon Corporation
Zeiss International
Ziemer Ophthalmic Systems AG
The Myopia and Presbyopia Treatment Market is expected to grow from USD 17,950 million in 2024 to approximately USD 33,969.73 million by 2032, reflecting a compound annual growth rate (CAGR) of 8.3% during the forecast period.
This expansion is primarily driven by the growing global prevalence of both myopia and presbyopia. Lifestyle changes—such as increased screen exposure and decreased outdoor activity—have contributed to a rise in myopia, especially among younger demographics. Concurrently, the global aging population has led to a higher incidence of presbyopia. Technological advancements in treatment options—including cutting-edge contact lenses, refractive surgeries, and emerging drug therapies—are significantly improving clinical outcomes and boosting demand. Rising disposable income levels and heightened public awareness regarding early vision care are also encouraging individuals to seek timely interventions. Furthermore, government-backed initiatives aimed at minimizing visual impairments are helping to support broader market growth.
Market Drivers
Technological Progress in Ophthalmic Treatments
Ongoing innovation in ophthalmology is enhancing the efficiency, accuracy, and accessibility of myopia and presbyopia treatments. New-generation contact lenses with multifocal features and advanced refractive surgeries such as LASIK and SMILE are gaining substantial traction. In parallel, pharmaceutical developments—such as low-dose atropine eye drops for managing myopia and investigational treatments targeting presbyopia’s root causes—are revolutionizing the therapeutic landscape. Notably, FDA-approved corneal inlays like KAMRA and Raindrop offer effective solutions for improving vision at multiple distances. These advances not only broaden treatment choices but also improve clinical success rates, contributing to increased market adoption and patient satisfaction.
Market Challenges
Cost Barriers Limiting Treatment Access
A major challenge hindering market growth is the high cost associated with advanced treatment options. Premium solutions, such as LASIK and SMILE procedures, customized contact lenses, and novel drug therapies, often come with significant out-of-pocket expenses. These treatments are not always covered by insurance, making them less accessible in low- and middle-income regions. Cost-related concerns remain a significant obstacle to widespread adoption, particularly among price-sensitive consumers, thus limiting the reach of advanced care solutions across diverse markets.
Market Segmentation
By Myopia Treatment Type:
Corrective Prescription Lenses:
Single
Bifocal
Trifocal
Others
Contact Lenses
Surgical
Drugs
By Presbyopia Treatment Type:
Prescription Lenses:
Reading Glasses
Bifocals
Trifocals
Progressive Multifocal
Office Progressives
Contact Lenses:
Bifocal
Multifocal
Monovision
Modified Monovision
Intraocular Lenses
Refractive Surgery
By Region:
North America: U.S., Canada, Mexico
Europe: Germany, France, U.K., Italy, Spain, Rest of Europe
Asia Pacific: China, Japan, India, South Korea, Southeast Asia, Rest of Asia Pacific
Latin America: Brazil, Argentina, Rest of Latin America
Middle East & Africa: GCC Countries, South Africa, Rest of the Middle East and Africa
Key Market Participants
ALCON VISION LLC
Bausch & Lomb Incorporated
Essilor Ltd.
Haag-Streit UK
Johnson & Johnson Vision
NIDEK CO., LTD.
Topcon Corporation
Zeiss International
Ziemer Ophthalmic Systems AG
Table of Contents
199 Pages
- CHAPTER NO. 1 : INTRODUCTION
- 1.1.1. Report Description
- Purpose of the Report
- USP & Key Offerings
- 1.1.2. Key Benefits for Stakeholders
- 1.1.3. Target Audience
- 1.1.4. Report Scope
- CHAPTER NO. 2 : EXECUTIVE SUMMARY
- 2.1. Myopia and Presbyopia Treatment Market Snapshot
- 2.1.1. Myopia and Presbyopia Treatment Market, 2018 - 2032 (USD Million)
- CHAPTER NO. 3 : Myopia and Presbyopia Treatment Market – INDUSTRY ANALYSIS
- 3.1. Introduction
- 3.2. Market Drivers
- 3.3. Market Restraints
- 3.4. Market Opportunities
- 3.5. Porter’s Five Forces Analysis
- CHAPTER NO. 4 : ANALYSIS COMPETITIVE LANDSCAPE
- 4.1. Company Market Share Analysis – 2023
- 4.2. Myopia and Presbyopia Treatment Market Company Revenue Market Share, 2023
- 4.3. Company Assessment Metrics, 2023
- 4.4. Start-ups /SMEs Assessment Metrics, 2023
- 4.5. Strategic Developments
- 4.6. Key Players Product Matrix
- CHAPTER NO. 5 : PESTEL & ADJACENT MARKET ANALYSIS
- CHAPTER NO. 6 : Myopia and Presbyopia Treatment Market – BY By Myopia Treatment Type: ANALYSIS
- CHAPTER NO. 7 : Myopia and Presbyopia Treatment Market – BY By Presbyopia Treatment Type: ANALYSIS
- CHAPTER NO. 8 : Myopia and Presbyopia Treatment Market – BY By Region: ANALYSIS
- CHAPTER NO. 9 : COMPANY PROFILES
- 9.1. ALCON VISION LLC
- 9.1.1. Company Overview
- 9.1.2. Product Portfolio
- 9.1.3. SWOT Analysis
- 9.1.4. Business Strategy
- 9.1.5. Financial Overview
- 9.2. Bausch & Lomb Incorporated
- 9.3. Essilor Ltd.
- 9.4. Haag-Streit UK
- 9.5. Johnson & Johnson Vision
- 9.6. NIDEK CO., LTD.
- 9.7. Topcon Corporation
- 9.8. Zeiss International
- 9.9. Ziemer Ophthalmic Systems AG
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
